| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
piperacillin
|
5 |
66.6 |
  |
| 2 |
ceftazidime
|
5 |
63.6 |
  |
| 3 |
imipenem
|
4 |
60.8 |
  |
| 4 |
HA
|
5 |
60.7 |
  |
| 5 |
amoxicillin plus clavulanic acid
|
3 |
48.0 |
  |
| 6 |
FEP
|
3 |
44.0 |
  |
| 7 |
P.
|
4 |
40.5 |
  |
| 8 |
cefotaxime
|
3 |
36.7 |
  |
| 9 |
BP86
|
2 |
33.4 |
  |
| 10 |
DZP
|
2 |
33.4 |
  |
| 11 |
Vitek
|
2 |
32.0 |
  |
| 12 |
aztreonam
|
2 |
31.7 |
  |
| 13 |
cephalosporins
|
2 |
31.2 |
  |
| 14 |
reference method
|
2 |
31.2 |
  |
| 15 |
estradiol
|
2 |
25.5 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
HA
|
5 |
56.8 |
  |
| 2 |
piperacillin
|
4 |
53.0 |
  |
| 3 |
amoxicillin plus clavulanic acid
|
3 |
45.6 |
  |
| 4 |
BP86
|
2 |
31.8 |
  |
| 5 |
DZP
|
2 |
31.8 |
  |
| 6 |
Vitek
|
2 |
30.4 |
  |
| 7 |
aztreonam
|
2 |
30.2 |
  |
| 8 |
imipenem
|
2 |
30.2 |
  |
| 9 |
FEP
|
2 |
29.6 |
  |
| 10 |
cephalosporins
|
2 |
29.6 |
  |
| 11 |
reference method
|
2 |
29.6 |
  |
| 12 |
P.
|
3 |
28.7 |
  |
| 13 |
ceftazidime
|
2 |
27.6 |
  |
| 14 |
MIC
|
2 |
22.3 |
  |
| 15 |
protein
|
2 |
16.8 |
  |
|
| 365 days (2008-12-20 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
aztreonam
|
2 |
24.2 |
  |
| 2 |
imipenem
|
2 |
24.2 |
  |
| 3 |
FEP
|
2 |
23.6 |
  |
| 4 |
reference method
|
2 |
23.6 |
  |
| 5 |
piperacillin
|
2 |
23.1 |
  |
| 6 |
ceftazidime
|
2 |
21.6 |
  |
| 7 |
P.
|
2 |
17.4 |
  |
| 8 |
CAS+S
|
1 |
13.6 |
  |
| 9 |
CAS+SD
|
1 |
13.6 |
  |
| 10 |
CAS-SCF
|
1 |
13.6 |
  |
| 11 |
DZ
|
1 |
13.6 |
  |
| 12 |
DZP
|
1 |
13.6 |
  |
| 13 |
H-Ar
|
1 |
13.6 |
  |
| 14 |
K-Kr
|
1 |
13.6 |
  |
| 15 |
SZ
|
1 |
13.6 |
  |
|